Ocufine Injection
Marketer
Neoveritas Healthcare Pvt. Ltd
Salt Composition
Octreotide acetate (100mcg)
Overview Ocufine Injection
Acromegaly, carcinoid tumors, and hemorrhaging esophageal varices are treated with Somalin Injection, which also prevents post-pancreatic surgery complications. Administration is exclusively by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal therapeutic effect; discontinuation should only occur under your doctor's guidance. Commonly reported side effects include nausea, diarrhea, abdominal discomfort, constipation, flatulence, and headache. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any liver conditions and a complete list of current medications to your doctor.
Uses of Ocufine Injection
Overgrowth of the extremities, carcinoid cancers, and esophageal variceal hemorrhage.
Major Benefits of Ocufine Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ocufine Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Ocufine Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ocufine Injection works:
Ocufine Injection mimics the action of somatostatin, an endogenous hormone regulator, suppressing the activity of several hormones including growth hormone. Its vasoconstrictive properties also reduce esophageal hemorrhage by narrowing blood vessels.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ocufine Injection may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
Administration of Ocufine Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Using Ocufine Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ocufine Injection.
KidneySAFE IF PRESCRIBED
Patients with renal impairment can safely receive Ocufine Injection without requiring any modification to the prescribed dosage.
LiverCAUTION
Patients with hepatic impairment should use Ocufine Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ocufine Injection :
Should you forget a dose of Ocufine Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ocufine Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin analogs |
| Developing Habits | No. |
| Type of Treatment | Endocrine Signals |
| Actions | Somatostatin receptor ligands |





